Physician profile
Ryan J Stokes
NPI 1073909966
$537.46
in general payments reported to CMS, 2019-2025
17 companies · $32.26 in 2025
The $32.26 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.44 · 2020: $97.07 · 2021: $61.68 · 2022: $148 · 2023: $21.22 · 2024: $93.17 · 2025: $32.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $89.83 | 2021-2025 | Pifeltro |
| Viiv Healthcare Company | $76.50 | 2024 | Apretude |
| Organon LLC | $61.57 | 2022-2023 | Nexplanon |
| Phadia US INC. | $35.39 | 2019-2020 | |
| Lilly USA, LLC | $34.08 | 2022 | |
| Gilead Sciences, INC. | $30.98 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $27.01 | 2019-2020 | |
| Abbvie INC. | $24.45 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $22.99 | 2019 | |
| Xeris Pharmaceuticals, INC. | $21.95 | 2022 | |
| Astellas Pharma US INC | $18.68 | 2019 | |
| Sanofi Pasteur INC. | $17.82 | 2022 | |
| Amgen INC. | $17.76 | 2019 | |
| Coopersurgical, INC. | $16.67 | 2024 | Paragard T 380a |
| Pfizer INC. | $16.43 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $13.08 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Stokes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.